An Updated Evidence-Based Practice Bundle for Blood Cultures

Recorded On: 06/14/2023

When diagnostic systems paint accurate pictures of patients, unnecessary and broad-spectrum antimicrobial use is reduced in favor of appropriate and targeted therapy, keeping antimicrobial resistance in check. Critical results demand that we give diagnostic tools and techniques the necessary development time to remain well ahead of the curve as therapeutic guidelines.  As clinicians we have the responsibility of ensuring that new evidence-based practices are incorporated into our patient care, keeping practice advancements pertinent to patient problems. In this session, the attendees will learn about the criticality of diagnostic accuracy and the associated cost of error, be equipped to assess clinical literature with an eye for evidence-driven opportunities to mitigate blood culture contamination, and learn how to best manage this practice change.

Learning Objectives: At the conclusion of this session, learners will be able to:

  • Review the history of antibiotic resistance detailing the causes and mechanisms of resistance.
  • Describe the impact of contaminated blood cultures on patients, antimicrobial stewardship efforts, quality patient outcomes, and hospital economics.
  • Interpret evidence-based clinical literature to drive a new standard of care for patient quality outcomes.
  • Discuss and influence how diagnostic and antimicrobial stewardship initiatives enhance local practices and progress global goals in health care.
  • Explain and employ tools and methods to implement and sustain new evidence-based practices. 

Tammy Johnson, BS, RN, CPM

Tammy Johnson, BS, RN, CPM, is the associate vice president of clinical strategy and customer relations at Magnolia Medical Technologies. With over 30 years in nursing and 20 years as a nurse leader and now executive in the medical device industry, Tammy’s focus remains on changing the standard of care to prevent both patient harm and the misspend of health care monies. Tammy holds degrees in nursing, business, and health care management;  has been evaluated as a highly engaging subject matter expert; has spoken at national meetings for the Association for Professionals in Infection Control and Epidemiology (APIC), the Infusion Nurses Society (INS), and the Association for Vascular Access (AVA); and been the keynote speaker for several state APIC meetings. She has also been the invited speaker for state hospital associations;  presented at national meetings for the Emergency Nurses Association (ENA), the American Organization for Nursing Leadership (AONL), and the American Hospital Association (AHA); and was  invited to present to the Presidential Advisory Council for Combating Antibiotic Resistant Bacteria in Washington, DC.

CRNI® RUs: This session has been approved for 2 CRNI® recertification units and meets the non INS Meeting criteria.

Contact Hours: This session has been approved for 1 contact hour

Expiration date for receipt of contact hours: June 14, 2026

To receive contact hours for this educational activity, you are required to attend the entire educational activity and complete the evaluation.

The Infusion Nurses Society is approved as a provider of continuing nursing education by the California Board of Registered Nursing, provider #CEP14209. The certificate must be retained by the attendee for a period of 4 years.


An Updated Evidence-Based Practice Bundle for Blood Cultures
Live event: 06/14/2023 at 1:00 PM (EDT) You must register to access.
Webinar Evaluation